This grant funds planning studies for clinical trials across the cancer prevention and control spectrum. It supports efforts to address critical information gaps in study populations, interventions, outcomes, and operational risks to improve trial design, feasibility, and cost-effectiveness. Topics include prevention, screening, early detection, healthcare delivery, symptom management, supportive care, and long-term survivor outcomes.
Eligible applicants include a wide range of U.S. institutions such as public and private higher education institutions, nonprofits, for-profit organizations, small businesses, tribal governments, and various government entities. Specific eligibility details are provided in the full announcement.
